Onfi
Drug - Onfi (clobazam) [Lundbeck]
November 2016
Therapeutic area - Antiepileptic
Approval criteria
- Patient has a diagnosis of Lennox-Gastaut Syndrome AND
- Patient has tried and failed THREE or more anti-epileptic drugs which include: clonazepam, valproate, lamotrigine or topiramate OR
- Prescriber is a neurologist and patient has tried and failed at least TWO anti-epileptic drugs which include: clonazepam, valproate, lamotrigine or topiramate
Quantity limits
- 10 mg tablets: 102 tablets per 34 days
- 20 mg tablets: 68 tablets
- Oral suspension (2.5 mg/mL): 600 mL per 34 days
Background information
ONFI (clobazam) is a benzodiazepine indicated for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
Questions?
MHCP Provider Call Center 651-431-2700 or 800-366-5411